PATENT CLAIM ANALYSIS

Application Number: 15873293
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "255050"]

Abstract:
Compositions of the invention comprise 1,2-dithiolane, dithiol and related compounds useful as therapeutic agents for the treatment and prevention of diseases and conditions associated with aberrant EGFR activity.

Claim (Index 20):
The method of  claim 17 , wherein the disease or condition associated with aberrant EGFR activity is lung cancer, non-small cell lung cancer, small cell lung cancer, glioblastoma multiforme, head and neck cancer, colon cancer, kidney cancer, ovarian cancer, prostate cancer, breast cancer, skin cancer, melanoma, blood cancer, leukemia, lymphoma, or malignant peripheral nerve sheath tumors.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15873255', '14913508', '16067444', '11048657', '14382074']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7779861877075234
- 35 USC 102 Novelty (BERT): 0.5414063171535477
- Combined Prediction Score: 0.7543282006521258
- Mean Citation Score: 330.21107600000005
- Max Citation Score: 363.78082
- Similarity Product: 216.6157770233488

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test